Parkinson's Disease

© GettyImages/Martin Barraud

4D Pharma sees positive data from early stage asthma trial

By Jane Byrne

Live biotherapeutic product (LBP) developer, 4D Pharma, which has been NASDAQ listed since March this year, has announced positive topline results for the first part of its Phase I/II trial of an LBP strain for the treatment of asthma.

Pic:getty/kotofeja

AC Immune acquires Parkinson’s vaccine candidate

By Rachel Arthur

AC Immune will acquire Affiris’ portfolio of therapeutics targeting alpha-synuclein (a-syn), which includes a vaccine candidate for the treatment of Parkinson’s disease.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers